A Clinical trial to study the effect of Triphla Gomutra Bhawit Trikatu Churna in the patient of hyperlipidemia

A Clinical Study to Evaluate the Efficacy of Triphla Gomutra Bhawit Trikatu Churna [TGT Capsule (Hypothetical)] in the Management of Medo Dushti w.s.r. to Hyperlipidemia - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/071946

Enrollment

100

Registered

2024-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E782- Mixed hyperlipidemia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing for the trial with consent. 2. The patients who age in between 20–70 years will be selected. 3. Patients with previously diagnosed and confirmed known patient of Hyperlipidemia. 4. The patients having clinical signs and symptoms due to Medo Dushti (Hyperlipidemia)

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 20 years and above 70 years. 2. Patients having major illness malignancy, renal insufficiency etc. 3. Heavy drinkers and drug abusers. 4. Pregnant and lactating women. 5. Patients having Peptic ulcers or any other bleeding disorders.

Design outcomes

Primary

Measure	Time frame
1.Kshudra Shwash (Dyspnoea)2. Sadan(Fatigue) 3.Daurgandhya (Bad Body Odour)4.Swedadhikya (Sweating)5.Snigdhata (Unctuous skin)6.Confusion like symptoms will be analysed Timepoint: 3 months	—

Secondary

Measure	Time frame
lipid profile will be analyzedTimepoint: 3 months	—

Countries

India

Contacts

Public ContactProf Ravi Sharma

MMM Govt Ayurved College,Udaipur

rspgkcj2015@gmail.com9414419259

Outcome results